Achiko AG announced that following pilot production with manufacturing partner PT Indofarma Tbk, the Company is now commencing commercial deliveries of its Generation 2 AptameX Covid-19 test kit to Nahdlatul Ulama (NU) and other commercial clients, both starting in and around Jakarta. Nahdlatul Ulama (DKI) is the Jakarta branch of Nahdlatul Ulama, which nationally in Indonesia has over 90 million registered members and operates over 6,000 schools and universities, and several hundred hospitals and clinics. Achiko had earlier in 2022 signed a marketing and sales agreement to deliver one million tests, before growing to five million per month in 2022.

AptameX is a saliva-based Covid-19 test using DNA Aptamers bound to gold nanoparticles in a colloidal solution, and the result is read by a UV Spectrophotometer and then analyzed with custom software. Unlike a molecular and immunoassay approaches, the test's use of DNA Aptamers has yielded encouraging results at low viral loads outperforming most lateral flow based rapid tests.